Martin Shkreli is famous for his love of hip hop, his Twitter and raising the price of life-saving anti-parasitic drug, Daraprim, from $13.50 to $750 per pill. Before his price gouging began at his current pharmaceutical company, Turing, he was the CEO of his own pharmaceutical company, Retrophin.
Now the poster boy for everything wrong in the healthcare industry has been arrested. Federal prosecuters are making a case against him involving securities fraud. A key part of his scheme involved using money from Retrophin to pay off a debt from his hedge fund that lost millions.
He's had ongoing problems with Retrophin since leaving/being ousted from the company. He has complained the company is trying to dodge paying him benefits that are due and, according to Bloomberg, Retrophin replaced him because they had "serious concerns about his conduct". Apparently they were right to be concerned.
His last tweet conversation is pretty ironic considering the circumstances:
He might have to learn to be humble in prison. At least he'll have something to occupy his time.